Michael Sassano

3 POSTS0 COMMENTS
Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centred on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing pharmaceutical products throughout the European Union. SOMAÍ opened Europe’s largest cannabis manufacturing facility earlier this year in Lisbon, Portugal.

TOP AUTHORS

59 POSTS0 COMMENTS
89 POSTS0 COMMENTS
3 POSTS0 COMMENTS
85 POSTS0 COMMENTS
3 POSTS0 COMMENTS
7 POSTS0 COMMENTS
62 POSTS0 COMMENTS
179 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
7 POSTS0 COMMENTS
87 POSTS0 COMMENTS
0 POSTS0 COMMENTS

Most Read